Second cord blood transplantation and interferon-α maintenance therapy for relapsed Ph⁺ acute lymphoblastic leukemia with the T315I mutation

Masahiko SumiDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan; Correspondence[email protected]

Keijiro SatoDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan; ;Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan

Hiroko KaiumeDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan;

Wataru TakedaDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan;

Takehiko KiriharaDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan;

Toshimitsu UekiDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan;

Yuki HiroshimaDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan;

Hikaru KobayashiDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan;

show all

Click to increase image sizeClick to decrease image size

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at http://dx.doi.org/10.1080/10428194.2016.1266623.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Second cord blood transplantation and interferon-α maintenance therapy for relapsed Ph⁺ acute lymphoblastic leukemia with the T315I mutation

Information for

Open access

Opportunities

Help and information

Second cord blood transplantation and interferon-α maintenance therapy for relapsed Ph+ acute lymphoblastic leukemia with the T315I mutation

Potential conflict of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature

Second cord blood transplantation and interferon-α maintenance therapy for relapsed Ph⁺ acute lymphoblastic leukemia with the T315I mutation